{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:03:05Z","timestamp":1790269385511,"version":"4.1.0"},"reference-count":131,"publisher":"Elsevier","isbn-type":[{"value":"9780443472169","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.05.009","type":"book-chapter","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:55:42Z","timestamp":1779825342000},"page":"447-485","source":"Crossref","is-referenced-by-count":0,"title":["Neurofilament light chain (NfL) as a biomarker for neurodegeneration: Protein biology, detection methods, and clinical applications"],"prefix":"10.1016","author":[{"given":"Niranjana","family":"Rajesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryona","family":"Joji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2026.05.009_bib1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures.\u00a0Alzheimer\u2019s & Dementia 20, 5 3708\u20133821 https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib2","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/19714009211024633","article-title":"Neurocritical care management of poor-grade subarachnoid hemorrhage: Unjustified nihilism to reasonable optimism","volume":"34","author":"Al-Mufti","year":"2021","journal-title":"The Neuroradiology Journal"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib4","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1038\/s41598-021-90639-z","article-title":"Seven day pre-analytical stability of serum and plasma neurofilament light chain","volume":"11","author":"Altmann","year":"2021","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-024-01883-z","article-title":"The neuropathological basis of elevated serum neurofilament light following experimental concussion","volume":"12","author":"Arena","year":"2024","journal-title":"Acta Neuropathologica Communications"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.009_bib6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1515\/cclm-2023-0036","article-title":"Neurofilament light chain as neuronal injury marker \u2013 what is needed to facilitate implementation in clinical laboratory practice?","volume":"61","author":"Arslan","year":"2023","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41531-025-00951-y","article-title":"Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism","volume":"11","author":"Baiardi","year":"2025","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cbf.3630","article-title":"Cellular and molecular mechanism in neurodegeneration: Possible role of neuroprotectants","volume":"39","author":"Basha","year":"2021","journal-title":"Cell Biochemistry and Function"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.009_bib11","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1515\/cclm-2023-1311","article-title":"Neurofilament light protein as a biomarker for spinal muscular atrophy: A review and reference ranges","volume":"62","author":"Bayoumy","year":"2024","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf129","article-title":"Novel insights into the molecular nature of neurofilament light polypeptide species in cerebrospinal fluid","volume":"7","author":"Becker","year":"2025","journal-title":"Brain Communications"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/jnnp-2022-330473","article-title":"A roadmap to ALS prevention: Strategies and priorities","volume":"94","author":"Benatar","year":"2023","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: A retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.irn.2026.05.009_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1608763","article-title":"High erythropoietin levels are associated with low neurofilament light levels in simulated high altitude: A further hint for neuroprotection by erythropoietin: A further hint for neuroprotection by erythropoietin","volume":"16","author":"Berek","year":"2025","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41398-021-01563-9","article-title":"Plasma neurofilament light as a potential biomarker for cognitive decline in a longitudinal study of middle-aged urban adults","volume":"11","author":"Beydoun","year":"2021","journal-title":"Translational Psychiatry"},{"key":"10.1016\/bs.irn.2026.05.009_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120447","article-title":"Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay","volume":"577","author":"Booth","year":"2025","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.irn.2026.05.009_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110668","article-title":"Impact of sex on neuroimmune contributions to Parkinson\u2019s disease","volume":"199","author":"Bourque","year":"2023","journal-title":"Brain Research Bulletin"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.009_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.45046","article-title":"Alzheimer disease blood biomarker concentrations across race and ethnicity groups in middle-aged adults","volume":"8","author":"Brickman","year":"2025","journal-title":"JAMA Network Open"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.009_bib20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ana.27145","article-title":"Towards a unified set of diagnostic criteria for multiple sclerosis","volume":"97","author":"Brownlee","year":"2025","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac045","article-title":"A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer\u2019s disease","volume":"4","author":"Budelier","year":"2022","journal-title":"Brain Communications"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.009_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","article-title":"Blood neurofilament light chain in Parkinson\u2019s disease","volume":"130","author":"Buhmann","year":"2023","journal-title":"Journal of Neural Transmission"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00415-025-13498-y","article-title":"Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: Insights from the UK Biobank","volume":"272","author":"Buonocore","year":"2025","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2026.05.009_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119975","article-title":"Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease","volume":"565","author":"Chen","year":"2025","journal-title":"Clinica Chimica Acta"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib26","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1038\/s41380-025-03149-z","article-title":"Plasma neurofilament light reflects more severe manifestation of Alzheimer\u2019s disease in men","volume":"30","author":"Cheng","year":"2025","journal-title":"Molecular Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/1352458519845287","article-title":"Deep grey matter involvement and altered sensory gating in multiple sclerosis","volume":"26","author":"Conte","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/bs.irn.2026.05.009_bib28","series-title":"The cell: A molecular approach","article-title":"Intermediate filaments","author":"Cooper","year":"2000"},{"key":"10.1016\/bs.irn.2026.05.009_bib29","first-page":"121","article-title":"Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population","author":"Cooper","year":"2023","journal-title":"Clinical Biochemistry"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acschemneuro.4c00526","article-title":"Neurofilament light chain under the lens of structural mass spectrometry","volume":"16","author":"Coppens","year":"2025","journal-title":"ACS Chemical Neuroscience"},{"issue":"14","key":"10.1016\/bs.irn.2026.05.009_bib31","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.3390\/ijms241411624","article-title":"Neurofilament-light, a promising biomarker: Analytical, metrological and clinical challenges","volume":"24","author":"Coppens","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae247","article-title":"Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer\u2019s disease","volume":"6","author":"Coulton","year":"2024","journal-title":"Brain Communications"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.009_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70343","article-title":"Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview","volume":"21","author":"Delaby","year":"2025","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.009_bib34","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/alz.12545","article-title":"Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease: An international overview","volume":"18","author":"Delaby","year":"2022","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/bs.irn.2026.05.009_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.952161","article-title":"Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990\u20132019","volume":"10","author":"Ding","year":"2022","journal-title":"Frontiers in Public Health"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.009_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pr.117.014647","article-title":"Neuroimmune axes of the blood\u2013brain barriers and blood\u2013brain interfaces: Bases for physiological regulation, disease states, and pharmacological interventions","volume":"70","author":"Erickson","year":"2018","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: Translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib40","first-page":"730","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer\u2019s disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta\u2010analysis","volume":"11","author":"Forgrave","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/bs.irn.2026.05.009_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"eBioMedicine"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23747","article-title":"Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport","volume":"72","author":"Freundt","year":"2012","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.009_bib43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","article-title":"A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: Analytical validation and clinical evaluation","volume":"10","author":"Gaetani","year":"2018","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.05.009_bib45","first-page":"15","article-title":"Detection and quantification of proteins in clinical samples using high resolution mass spectrometry","volume":"81","author":"Gallien","year":"2015","journal-title":"Methods, Detection and Quantification of Proteins in Clinical Samples Using Mass Spectrometry"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.009_bib46","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61655-6","article-title":"Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in subjective cognitive decline and mild cognitive impairment","volume":"14","author":"Giacomucci","year":"2024","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease: Models, mechanisms, and a new hope","volume":"10","author":"Gitler","year":"2017","journal-title":"Disease Models & Mechanisms"},{"key":"10.1016\/bs.irn.2026.05.009_bib49","series-title":"Handbook of neuroemergency clinical trials","first-page":"139","article-title":"The use of blood-based biomarkers to improve the design of clinical trials of traumatic brain injury","author":"Glushakova","year":"2018"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13195-024-01593-7","article-title":"Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study","volume":"16","author":"G\u00f6tze","year":"2024","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.05.009_bib51","doi-asserted-by":"crossref","DOI":"10.1101\/2024.11.21.24317697","article-title":"Neurofilament light chain reference values in serum and cerebrospinal fluid: A bi-compartmental analysis in neurological diseases","author":"Halbgebauer","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.05.009_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.trac.2017.08.009","article-title":"Antibody based affinity capture LC-MS\/MS in quantitative determination of proteins in biological matrices","volume":"95","author":"Halvorsen","year":"2017","journal-title":"TrAC Trends in Analytical Chemistry"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nature Aging"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.14802\/jmd.24075","article-title":"\u03b1-Synuclein: A promising biomarker for Parkinson\u2019s disease and related disorders","volume":"17","author":"Hatano","year":"2024","journal-title":"Journal of Movement Disorders"},{"key":"10.1016\/bs.irn.2026.05.009_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fnagi.2018.00305","article-title":"Recent advances in biomarkers for Parkinson\u2019s disease","volume":"10","author":"He","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.009_bib56","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s43587-024-00683-3","article-title":"Challenges and recommendations for the translation of biomarkers of aging","volume":"4","author":"Herzog","year":"2024","journal-title":"Nature Aging"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib57","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1038\/s41467-024-52937-8","article-title":"Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer\u2019s disease","volume":"15","author":"Hofmann","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/bs.irn.2026.05.009_bib58","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04160","article-title":"Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide","volume":"13","author":"Huang","year":"2023","journal-title":"Journal of Global Health"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/00365513.2020.1730434","article-title":"Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults","volume":"80","author":"Hviid","year":"2020","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1016\/bs.irn.2026.05.009_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1477047","article-title":"Preliminary reference values for Alzheimer\u2019s disease plasma biomarkers in Congolese individuals with and without dementia","volume":"16","author":"Ikanga","year":"2024","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"147","key":"10.1016\/bs.irn.2026.05.009_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.irn.2026.05.009_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1614962","article-title":"Biological determinants of blood-based biomarker levels in Alzheimer\u2019s disease: Role of nutrition, inflammation, and metabolic factors","volume":"17","author":"Inamdar","year":"2025","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.009_bib63","series-title":"Advancements of mass spectrometry in biomedical research","article-title":"Immuno-affinity mass spectrometry: A novel approaches with biomedical relevance","author":"Ion","year":"2019"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/bs.irn.2026.05.009_bib65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","article-title":"Role of neurofilament light chain as a potential biomarker for Alzheimer\u2019s disease: A correlative meta-analysis","volume":"11","author":"Jin","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awad267","article-title":"The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer\u2019s disease","volume":"147","author":"Jung","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/medicina58030433","article-title":"Serum NfL in Alzheimer dementia: Results of the prospective dementia registry Austria","volume":"58","author":"Kern","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/bs.irn.2026.05.009_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2015.00044","article-title":"The axonal cytoskeleton: From organization to function","volume":"8","author":"Kevenaar","year":"2015","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u2014Towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nature Reviews Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.009_bib70","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"15","key":"10.1016\/bs.irn.2026.05.009_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158132","article-title":"Clinical application of blood biomarkers in neurodegenerative diseases\u2014Present and future perspectives","volume":"25","author":"Krawczuk","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.009_bib72","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib73","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1177\/1352458515623365","article-title":"Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity","volume":"22","author":"Kuhle","year":"2016","journal-title":"Multiple Sclerosis Journal"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/13524585211032348","article-title":"Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing\u2013remitting MS","volume":"28","author":"Kuhle","year":"2022","journal-title":"Multiple Sclerosis Journal"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.009_bib75","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: Time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.irn.2026.05.009_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251364018","article-title":"Advancing clinical use of neurofilament light chain: Translational insights from research to routine practice","volume":"20","author":"La Civita","year":"2025","journal-title":"Biomarker Insights"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.009_bib78","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00415-025-13246-2","article-title":"Longitudinal evaluation of serum neurofilament light levels in normal healthy volunteers: Defining a threshold of concern","volume":"272","author":"Lanz","year":"2025","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae132","article-title":"CSF neurofilament light chain profiling and quantitation in neurological diseases","volume":"6","author":"Leckey","year":"2024","journal-title":"Brain Communications"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib80","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jalz.2016.08.013","article-title":"Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer\u2019s disease","volume":"13","author":"Leeuwis","year":"2017","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib81","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","article-title":"Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry","volume":"19","author":"Lewczuk","year":"2018","journal-title":"The World Journal of Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","article-title":"An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform","volume":"8","author":"Li","year":"2019","journal-title":"Neurology and Therapy"},{"key":"10.1016\/bs.irn.2026.05.009_bib83","article-title":"Neurofilament light as a biomarker for motor decline in Parkinson\u2019s disease","volume":"16","author":"Liu","year":"2022","journal-title":"Frontiers in Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000525639","article-title":"Descriptive epidemiology of neurodegenerative diseases: What are the critical questions?","volume":"56","author":"Logroscino","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib85","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s43587-025-00851-z","article-title":"Pre-symptomatic Parkinson\u2019s disease blood test quantifying repetitive sequence motifs in transfer RNA fragments","volume":"5","author":"Madrer","year":"2025","journal-title":"Nature Aging"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40035-024-00426-9","article-title":"Ultrasensitive detection of aggregated \u03b1-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson\u2019s disease","volume":"13","author":"Mao","year":"2024","journal-title":"Translational Neurodegeneration"},{"issue":"13","key":"10.1016\/bs.irn.2026.05.009_bib87","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL discriminates Parkinson disease from atypical parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib88","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1038\/s41467-020-19957-6","article-title":"Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies","volume":"11","author":"Mattsson-Carlgren","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16089","article-title":"Plasma neurofilament light chain predicts Alzheimer\u2019s disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study","volume":"31","author":"Mazzeo","year":"2024","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib90","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.05.009_bib91","unstructured":"Mullard, A. (2023). NfL makes regulatory debut as neurodegenerative disease biomarker 2023. https:\/\/www.nature.com\/articles\/d41573-023-00083-z."},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib93","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma biomarkers of Alzheimer\u2019s disease: A review of available assays, recent developments, and implications for clinical practice","volume":"7","author":"Pais","year":"2023","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"key":"10.1016\/bs.irn.2026.05.009_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120730","article-title":"Alpha-synuclein in skin as a high-quality biomarker for Parkinson\u2019s disease","volume":"451","author":"Peng","year":"2023","journal-title":"Journal of the Neurological Sciences"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.009_bib95","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","article-title":"Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics","volume":"11","author":"Peterson","year":"2012","journal-title":"Molecular & Cellular Proteomics"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib96","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","article-title":"Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson\u2019s disease","volume":"271","author":"Pilotto","year":"2024","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib97","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","article-title":"Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: A secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial","volume":"79","author":"Pontecorvo","year":"2022","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","article-title":"Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib100","article-title":"Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer\u2019s disease","volume":"12","author":"Raket","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.009_bib101","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.05.009_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.894119","article-title":"A method to combine neurofilament light measurements from blood serum and plasma in clinical and population-based studies","volume":"13","author":"R\u00fcbsamen","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2026.05.009_bib103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2015.03.041","article-title":"Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson\u2019s disease from atypical parkinsonism: Evidence from a meta-analysis","volume":"352","author":"Sako","year":"2015","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.009_bib104","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2023-331051","article-title":"Association of serum neurofilament light with microglial activation in multiple sclerosis","volume":"94","author":"Saraste","year":"2023","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib105","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1152\/jn.00989.2014","article-title":"Modeling and simulating the neuromuscular mechanisms regulating ankle and knee joint stiffness during human locomotion","volume":"114","author":"Sartori","year":"2015","journal-title":"Journal of Neurophysiology"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.009_bib106","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000200358","article-title":"Effect of race on prediction of brain amyloidosis by plasma A\u03b242\/A\u03b240, phosphorylated tau, and neurofilament light","volume":"99","author":"Schindler","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.009_bib107","doi-asserted-by":"crossref","first-page":"119","DOI":"10.37349\/ent.2024.00075","article-title":"Biomarkers in neurodegenerative diseases: A broad overview","volume":"4","author":"Selvam","year":"2024","journal-title":"Exploration of Neuroprotective Therapy"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Communications"},{"issue":"23","key":"10.1016\/bs.irn.2026.05.009_bib109","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207957","article-title":"Agreement between published reference resources for neurofilament light chain levels in people with multiple sclerosis","volume":"101","author":"Sotirchos","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010061","article-title":"Neurofilament light protein as a biomarker in severe mental disorders: A systematic review","volume":"26","author":"Squitti","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.009_bib111","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: Modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib112","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: From physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiological Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2026.05.009_bib114","article-title":"Neurofilament light (NfL) chain levels predict clinical decline in Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"9","author":"Thomas","year":"2025","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"issue":"29","key":"10.1016\/bs.irn.2026.05.009_bib115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1221835110","article-title":"Severing and end-to-end annealing of neurofilaments in neurons","volume":"110","author":"Uchida","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.irn.2026.05.009_bib116","series-title":"Advances in clinical chemistry","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.acc.2025.01.006","article-title":"Advances in neurofilament light chain analysis","author":"Uzgiris","year":"2025"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66728-2","article-title":"Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community","volume":"16","author":"Valletta","year":"2025","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.009_bib118","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1515\/cclm-2022-0007","article-title":"Pre-analytical stability of serum biomarkers for neurological disease: Neurofilament-light, glial fibrillary acidic protein and contactin-1","volume":"60","author":"Van Lierop","year":"2022","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib119","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamaneurol.2024.5017","article-title":"Detection of Alzheimer neuropathology in alzheimer and non-alzheimer clinical syndromes with blood-based biomarkers","volume":"82","author":"VandeVrede","year":"2025","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2026.05.009_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib121","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000422","article-title":"Neurofilament light chain predicts disease activity in relapsing-remitting MS","volume":"5","author":"Varhaug","year":"2018","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.009_bib122","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre\u2010analytical sample handling effects on a panel of Alzheimer\u2019s disease\u2013related blood\u2010based biomarkers: Results from the standardization of Alzheimer\u2019s blood biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.009_bib123","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/alz.13314","article-title":"Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer\u2019s disease","volume":"19","author":"Vila\u2010Castelar","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"13","key":"10.1016\/bs.irn.2026.05.009_bib124","first-page":"947","article-title":"Quality management in clinical application of mass spectrometry measurement systems","volume":"49","author":"Vogeser","year":"2016","journal-title":"Clinical Biochemistry, Mass Spectrometry"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib125","article-title":"Clinical performance of scalable automated p\u2010tau 217 multi\u2010analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay","volume":"17","author":"Wilson","year":"2025","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib126","article-title":"Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI","volume":"14","author":"Windon","year":"2022","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/bs.irn.2026.05.009_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106356","article-title":"Trajectories of CSF and plasma biomarkers across Alzheimer\u2019s disease continuum: Disease staging by NF-L, p-tau181, and GFAP","volume":"189","author":"Wojda\u0142a","year":"2023","journal-title":"Neurobiology of Disease"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.009_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70934","article-title":"Combined use of plasma p\u2010tau217, NfL, and GFAP predicts domain\u2010specific cognitive decline in cognitively unimpaired and MCI individuals","volume":"21","author":"Wu","year":"2025","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3343\/alm.2024.0611","article-title":"Advances in circulating biomarkers for neurodegenerative diseases, traumatic brain injuries, and central nervous system tumors","volume":"45","author":"Yang","year":"2025","journal-title":"Annals of Laboratory Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.009_bib130","doi-asserted-by":"crossref","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.009_bib131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: Towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Molecular Neurodegeneration"}],"container-title":["International Review of Neurobiology","Blood-Based Biomarkers for Alzheimers and Parkinsons Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:19:44Z","timestamp":1790266784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443472169"],"references-count":131,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.05.009","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}